Costanzo, A. (2021) “Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study”, Acta Dermato-Venereologica, 101(10), p. adv00576. doi: 10.2340/00015555-3816.